Automation index
How much of a Stockbroker’s job can AI already do?
An order and a note come earlier. Calling someone when the market is sinking does not.
This percentage does not predict how many people will lose their jobs.
Task comparison
IS WORK OVER?
Stockbroker
25%
AI can already do 25% of this job.
#224 / 643
View rankingStockbroker
Where the time goes
Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.
The time saving for each task is estimated separately.
| Task | Share | AI | Points |
|---|---|---|---|
Orders, notes and portfolio screens.EstimateNo public source provides a precise figure. This is our estimate. | 18% | 48% | +8.6 |
Analysis, theses and market notes.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 28% | +4.5 |
Call, persuade and not over-push.EstimateNo public source provides a precise figure. This is our estimate. | 18% | 18% | +3.2 |
Compliance, KYC and recordings.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 22% | +3.5 |
Desk, hours and execution issues.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 16% | +2.6 |
Not putting a client into something they do not understand.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 14% | +2.2 |
| Total | 100% | 25% |
Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low
Skills and activities
- Orders, notes and portfolio screens
- Analysis, theses and market notes
- Call, persuade and not over-push
- Compliance, KYC and recordings
- Desk, hours and execution issues
- corredor de bolsa
- broker
- agente de bolsa
Sources for this job· O*NET 41-3031.00· ESCO/ISCO 3311
IS WORK OVER?
Hepatologist
27%
#158 / 643
View rankingHepatologist
Where the time goes
Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.
The time saving for each task is estimated separately.
| Task | Share | AI | Points |
|---|---|---|---|
Labs, fibroscan and the stage.EstimateNo public source provides a precise figure. This is our estimate. | 18% | 48% | +8.6 |
Clinic, the drink and the one who denies it.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 40% | +6.4 |
Biopsy, the risk and not needling extra.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 22% | +3.5 |
Antiviral, adherence and the one who quits.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 28% | +4.5 |
The transplant board and not jumping to a yes.EstimateNo public source provides a precise figure. This is our estimate. | 18% | 14% | +2.5 |
Call the liver, and talking to the family.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 12% | +1.9 |
| Total | 100% | 27% |
Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low
Skills and activities
- fibroscan
- liver biopsy
- hepatitis
- cirrhosis
- liver transplant
- antivirals
- liver clinic
- decompensation
Sources for this job· O*NET 29-1216.00· ESCO/ISCO 2212